Cargando…

Mass Cytometry of CSF Identifies an MS-Associated B-cell Population

OBJECTIVE: To identify an MS-specific immune cell population by deep immune phenotyping and relate it to soluble signaling molecules in CSF. METHODS: We analyzed surface expression of 22 markers in paired blood/CSF samples from 39 patients using mass cytometry (cytometry by time of flight). We also...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johansson, David, Rauld, Céline, Roux, Julien, Regairaz, Camille, Galli, Edoardo, Callegari, Ilaria, Raad, Layla, Waldt, Annick, Cuttat, Rachel, Roma, Guglielmo, Diebold, Martin, Becher, Burkhard, Kuhle, Jens, Derfuss, Tobias, Carballido, José M., Sanderson, Nicholas S.R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057060/ https://www.ncbi.nlm.nih.gov/pubmed/33589541 http://dx.doi.org/10.1212/NXI.0000000000000943

Ejemplares similares

The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases
por: Carballido, José M., et al.
Publicado: (2020)

Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia
por: Diebold, Martin, et al.
Publicado: (2022)

High-dimensional immune profiling identifies a biomarker to monitor dimethyl fumarate response in multiple sclerosis
por: Diebold, Martin, et al.
Publicado: (2022)

GM-CSF and CXCR4 Define a T Helper Cell Signature in Multiple Sclerosis
por: Galli, Edoardo, et al.
Publicado: (2019)

GPR91 deficiency exacerbates allergic contact dermatitis while reducing arthritic disease in mice
por: Rubić‐Schneider, T., et al.
Publicado: (2016)

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy
por: Rust, Heiko, et al.
Publicado: (2016)

Fingerprints of CD8(+) T cells on human pre-plasma and memory B cells
por: Strittmatter-Keller, Ulrike, et al.
Publicado: (2018)

CellSIUS provides sensitive and specific detection of rare cell populations from complex single-cell RNA-seq data
por: Wegmann, Rebekka, et al.
Publicado: (2019)

Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities
por: Rose, Natalie, et al.
Publicado: (2022)

Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis
por: Callegari, Ilaria, et al.
Publicado: (2023)

Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis
por: Wang, Zhong-Yi, et al.
Publicado: (2021)

T Cell Contamination in Flow Cytometry Gating Approaches for Analysis of Innate Lymphoid Cells
por: Burkhard, Sara H., et al.
Publicado: (2014)

Hepatitis E virus infections in patients with MS on oral disease-modifying treatment
por: Diebold, Martin, et al.
Publicado: (2019)

The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis
por: Diebold, Martin, et al.
Publicado: (2019)

Lymphocyte recovery after fingolimod discontinuation in patients with MS
por: Nagy, Sara, et al.
Publicado: (2020)

Potent neutralization by monoclonal human IgM against SARS‐CoV‐2 is impaired by class switch
por: Callegari, Ilaria, et al.
Publicado: (2022)

Self-organization and symmetry breaking in intestinal organoid development
por: Serra, Denise, et al.
Publicado: (2019)

Imaging Mass Cytometry and Single-Cell Genomics Reveal Differential Depletion and Repletion of B-Cell Populations Following Ofatumumab Treatment in Cynomolgus Monkeys
por: Theil, Diethilde, et al.
Publicado: (2019)

GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
por: Lang, Frederick M., et al.
Publicado: (2020)

Les poémes de Jean Cuttat.
por: Cuttat, Jean
Publicado: (1989)

CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets
por: Nowicka, Malgorzata, et al.
Publicado: (2019)

Chemokine CXCL13 in serum, CSF and blood–CSF barrier function: evidence of compartment restriction
por: Pilz, Georg, et al.
Publicado: (2020)

Gut microbiota composition as a candidate risk factor for dimethyl fumarate-induced lymphopenia in multiple sclerosis
por: Diebold, Martin, et al.
Publicado: (2022)

Identification of a novel NAMPT inhibitor by CRISPR/Cas9 chemogenomic profiling in mammalian cells
por: Estoppey, David, et al.
Publicado: (2017)

An alternative flow cytometry strategy for peripheral blood dendritic cell enumeration in the setting of repetitive GM-CSF dosing
por: Wang, Kehui, et al.
Publicado: (2006)

IL-27, but not IL-35, inhibits neuroinflammation through modulating GM-CSF expression
por: Casella, Giacomo, et al.
Publicado: (2017)

B Cells and Autoantibodies in Multiple Sclerosis
por: Pröbstel, Anne-Katrin, et al.
Publicado: (2015)

Alveolar macrophages rely on GM-CSF from alveolar epithelial type 2 cells before and after birth
por: Gschwend, Julia, et al.
Publicado: (2021)

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
por: Juvet, Stephen C., et al.
Publicado: (2017)

Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PML
por: Fischer-Barnicol, Bettina, et al.
Publicado: (2020)

CSF neurofilament light chain reflects corticospinal tract degeneration in ALS
por: Menke, Ricarda A L, et al.
Publicado: (2015)

Quantified CSF antibody reactivity against myelin in multiple sclerosis
por: Sun, Xingwen, et al.
Publicado: (2015)

Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus
por: Margraf, Nils G., et al.
Publicado: (2023)

Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease
por: Steinacker, Petra, et al.
Publicado: (2016)

The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes
por: Anzai, Atsushi, et al.
Publicado: (2017)

Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal Bands
por: Probert, Fay, et al.
Publicado: (2022)

Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis
por: Lorscheider, Johannes, et al.
Publicado: (2020)

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
por: Kuhle, Jens, et al.
Publicado: (2015)

Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS
por: Zimmermann, Maria, et al.
Publicado: (2015)

Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands
por: Probert, Fay, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nrhctjphj3hoe812hhg44u1mgs